Prakash Diwan, Director of Altamount Capital Management is of the view that one may look at Camson Bio Technologies with a target of Rs 180.
first published: Apr 28, 2015 11:30 am
A collection of the most-viewed Moneycontrol videos.
Live: Sensex, Nifty fall 1% amidst broad-based selloff | Closing Bell
Live: Can Nifty reclaim record levels as investors await FOMC decision this week? | Opening Bell
Why This Tenant Says Bandra Is Better Than California | The Tenant
Nifty Clocks Triple-Digit Gains After RBI Rate Cut But Logs Losses For The Week| Closing Bell Live
